Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study.
Wang QX, Xiao BY, Cheng Y, Wu AW, Zhang T, Wang H, Zhang X, Huang WX, Tang JH, Jiang W, Steele SR, Krishnamurthi S, Li Y, Cai J, Kong LH, Li DD, Pan ZZ, Zhang XS, Ding PR.
Wang QX, et al. Among authors: xiao by.
Eur J Cancer. 2022 Oct;174:176-184. doi: 10.1016/j.ejca.2022.07.016. Epub 2022 Aug 26.
Eur J Cancer. 2022.
PMID: 36030556
Free article.